Pregnancy Alerts as Drugmaker Accepts Contraceptive Slip-up
Submitted by Kamilah Qasimi on Thu, 02/02/2012 - 12:18
In a shocking incident, it has been revealed that the world’s biggest drug company, Pfizer, has summoned up in excess of 1 million packs of contraceptive pills following a recent disclosure in which it was revealed that the birth-control pills were muddled up in packs. As a result, claims are being made that a large number of women might be at the risk of unwanted or unintended pregnancy.
FDA Gives Green Signal to Pfizer’s INYLTA
Submitted by Suresh Lalwani on Mon, 01/30/2012 - 13:02
As per reports, it has been revealed that the Food and Drug Administration (FDA) has given a green signal to Pfizer for its new oral treatment INLYTA. The oral drug is meant for patients who have been suffering from advanced Renal Cell Carcinoma (RCC).
Novartis Unit to Take $120 Million Charge on Recall
Submitted by Latika Sharma on Mon, 01/09/2012 - 12:56
As per latest reports, it has been revealed that the consumer health unit of Novartis will be taking a $120 million bump during the fourth quarter following the move in which the Swiss drug manufacturer settled on voluntarily recalling a handful of products in the US and move towards enhancing high standards of quality at its manufacturing locations.
Bionomics Strikes A Deal with Ironwood for Developing and Commercializing Drug BNC210
Submitted by Kanika Mehta on Fri, 01/06/2012 - 11:34
Yesterday, Bionomics broke the announcement of striking a deal with the US Drug Company Ironwood for developing and commercializing anti-anxiety drug BNC210. The deal would increase the revenue of the firm as it will be receiving a payment of US$3 million and US$13 million in the coming two years.
Huge State Payments for Pharma Firms
Submitted by Latika Sharma on Fri, 12/23/2011 - 12:42
In the new figures revealed by Irish authorities, it has been said that Abbey Healthcare from Dublin has earned a huge sum of _1m. They have been given this sum by the Health Service Executive in Dun Laoghaire from Dublin. This has been given to them for the effective drug dispensing they have done under numerous health schemes last year.
Generic Oppugners Jockey for Position, Lipitor's Sales Bisected
Submitted by Gunraj Sandhu on Tue, 12/20/2011 - 09:51
As per the data released by IMS on Monday, it has been revealed that in excess of 476,000 fresh prescriptions in context of generic Lipitor, mainly dubbed as atorvastatin, were to the top right through the week ended on December 9. In addition, it has been found that almost 80% prescriptions were meant for the generic version of Watson.
